While TDO overexpression in tumor cells can promote tumor growth through suppression of the anti-tumor immune response (35, 36), inhibition of TDO can restore tumor suppression (35) and enhance the efficacy of CTLA-4 blockade therapy (319). This evidence concerns the gene TDO2 and neoplasm.